These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23397289)

  • 1. Atrial fibrillation and stroke: the evolving role of rhythm control.
    Patel TK; Passman RS
    Curr Treat Options Cardiovasc Med; 2013 Jun; 15(3):299-312. PubMed ID: 23397289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate versus rhythm control in atrial fibrillation.
    Wijffels MC; Crijns HJ
    Cardiol Clin; 2004 Feb; 22(1):63-9. PubMed ID: 14994848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial.
    Kirchhof P; Breithardt G; Camm AJ; Crijns HJ; Kuck KH; Vardas P; Wegscheider K
    Am Heart J; 2013 Sep; 166(3):442-8. PubMed ID: 24016492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits and risks of catheter ablation in elderly patients with atrial fibrillation.
    Nademanee K; Amnueypol M; Lee F; Drew CM; Suwannasri W; Schwab MC; Veerakul G
    Heart Rhythm; 2015 Jan; 12(1):44-51. PubMed ID: 25257091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic management of atrial fibrillation: established and emerging options.
    Kalus JS
    J Manag Care Pharm; 2009 Aug; 15(6 Suppl B):S10-8. PubMed ID: 19678722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cabins, castles, and constant hearts: rhythm control therapy in patients with atrial fibrillation.
    Willems S; Meyer C; de Bono J; Brandes A; Eckardt L; Elvan A; van Gelder I; Goette A; Gulizia M; Haegeli L; Heidbuchel H; Haeusler KG; Kautzner J; Mont L; Ng GA; Szumowski L; Themistoclakis S; Wegscheider K; Kirchhof P
    Eur Heart J; 2019 Dec; 40(46):3793-3799c. PubMed ID: 31755940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of sinus rhythm in patients with "permanent" atrial fibrillation.
    Ziegler PD; Sakaguchi S; Simons GR; Koehler JL; Warman E
    Pacing Clin Electrophysiol; 2014 Jun; 37(6):674-81. PubMed ID: 24499313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of rhythm control in persistent or permanent atrial fibrillation with overdrive atrial pacing and antiarrhythmic drugs after linear right atrial catheter ablation.
    Filipecki A; Saksena S; Lin WH
    Am J Cardiol; 2003 Nov; 92(9):1037-44. PubMed ID: 14583353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic Drug Therapy for Rhythm Control in Atrial Fibrillation.
    Waks JW; Zimetbaum P
    J Cardiovasc Pharmacol Ther; 2017 Jan; 22(1):3-19. PubMed ID: 27260643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of insertable cardiac monitors in anticoagulation therapy in patients with atrial fibrillation at high risk of bleeding.
    Mascarenhas DA; Farooq MU; Ziegler PD; Kantharia BK
    Europace; 2016 Jun; 18(6):799-806. PubMed ID: 26614520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate versus rhythm control in patients with atrial fibrillation: what the trials really say.
    Crijns HJ
    Drugs; 2005; 65(12):1651-67. PubMed ID: 16060699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced electrophysiologic mapping systems: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(8):1-101. PubMed ID: 23074499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term oral anticoagulant after catheter ablation for atrial fibrillation.
    Chew D; Piccini JP
    Europace; 2021 Aug; 23(8):1157-1165. PubMed ID: 33400774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation: a review of mechanism, etiology, and therapy.
    Mackstaller LL; Alpert JS
    Clin Cardiol; 1997 Jul; 20(7):640-50. PubMed ID: 9220181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The RACE study in perspective of randomized studies on management of persistent atrial fibrillation.
    Hagens VE; Van Gelder IC; Crijns HJ;
    Card Electrophysiol Rev; 2003 Jun; 7(2):118-21. PubMed ID: 14618033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current management of symptomatic atrial fibrillation.
    Haghi D; Schumacher B
    Am J Cardiovasc Drugs; 2001; 1(2):127-39. PubMed ID: 14728042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Atrial Fibrillation: How Important is Rhythm Control Therapy?].
    Meyer C; Metzner A; Kirchhof P
    Dtsch Med Wochenschr; 2020 Apr; 145(8):543-549. PubMed ID: 32294780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of atrial fibrillation.
    Hersi A; Wyse DG
    Curr Probl Cardiol; 2005 Apr; 30(4):175-233. PubMed ID: 15778690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The WATCHMAN left atrial appendage closure device for atrial fibrillation.
    Möbius-Winkler S; Sandri M; Mangner N; Lurz P; Dähnert I; Schuler G
    J Vis Exp; 2012 Feb; (60):. PubMed ID: 22395336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhythm course over 5 years following surgical ablation for atrial fibrillation.
    Ad N; Holmes SD; Stone LE; Pritchard G; Henry L
    Eur J Cardiothorac Surg; 2015 Jan; 47(1):52-8; discussion 58. PubMed ID: 24585551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.